Zynerba Prescribed drugs (ZYNE) closed the newest buying and selling day at $4.50, transferring +0.78% from the earlier buying and selling session. This transfer outpaced the S&P 500’s each day lack of 0.48%. On the similar time, the Dow misplaced 1.5%, and the tech-heavy Nasdaq gained 0.56%. www.nasdaq.com
Zynerba Prescribed drugs (ZYNE) closed the newest buying and selling day at $4.50, transferring +0.78% from the earlier buying and selling session. This transfer outpaced the S&P 500’s each day lack of 0.48%. On the similar time, the Dow misplaced 1.5%, and the tech-heavy Nasdaq gained 0.56%.
www.nasdaq.com